Revolax Fine Regulatory and Market Access Status for Aesthetic Professionals

Revolax Fine is a hyaluronic acid (HA) dermal filler manufactured by Across Biotech in South Korea. It is formulated for specific aesthetic applications, requiring precise handling and administration by trained practitioners. Professionals often seek to stock a range of dependable HA fillers for varied treatment needs, from fine lines to deeper volume restoration. Explore our Hyaluronic acid dermal filler catalog for a comprehensive selection.

Knowing the manufacturer's background and product origin is a key component of due diligence when sourcing injectables. Across Biotech is a recognized producer in the aesthetic medical device sector, originating from a region known for its advancements in dermatological science.

The regulatory landscape for aesthetic injectables requires specific certifications to ensure product quality and safety. For Revolax Fine, several key approvals and standards are pertinent:

• CE Mark: Revolax Fine holds a CE Mark [VERIFY: exact CE Class and current status]. This certification indicates compliance with European health, safety, and environmental protection standards for products sold within the European Economic Area (EEA).
• KFDA Approval: As a product of South Korea, Revolax Fine is approved by the Korean Ministry of Food and Drug Safety (KFDA). KFDA approval is a stringent regulatory benchmark for medical devices within South Korea, overseeing manufacturing quality and product specifications.
• FDA Status (USA): Revolax Fine is not currently FDA approved for sale or use in the United States. Professionals in the U.S. should note that sourcing non-FDA approved products for direct use carries specific regulatory implications.
• GMP & ISO Certifications: Across Biotech, the manufacturer, operates under Good Manufacturing Practice (GMP) guidelines and typically holds ISO 13485 certification [VERIFY: current ISO 13485 certification status]. These international standards confirm a robust quality management system for medical device production.

The legal availability of Revolax Fine varies by geographic region due to differing national regulatory frameworks. Clinics must confirm local compliance before sourcing:

• European Union (EU) & United Kingdom (UK): The CE Mark permits legal distribution within the EU. For the UK, products with a CE Mark continue to be recognized, though the UK's medical device regulations are evolving post-Brexit, potentially requiring future UKCA marking for new products entering the market.
• GCC Countries (Gulf Cooperation Council): Market access in the UAE, Saudi Arabia, Qatar, and other GCC nations often requires local registration with national health authorities, frequently referencing EU or U.S. standards. Suppliers must provide documentation demonstrating this local clearance.
• Latin America (LATAM): Regulations across LATAM are diverse. Countries like Brazil (ANVISA), Mexico (COFEPRIS), and Colombia (INVIMA) have their own strict registration processes. Products may be imported under specific permits or require full local approval.
• APAC Region (Asia-Pacific): Beyond South Korea, availability in countries like Singapore (HSA), Australia (TGA), and others is dependent on their respective national medical device regulations and approval processes. Professionals should always confirm current local status.

Parallel importing involves sourcing products outside official distribution channels. While sometimes perceived as cost-effective, it presents notable risks for aesthetic clinics. These risks include uncertain product origin, lack of traceability, potential deviations from recommended cold chain storage, and absence of manufacturer support or warranty.

To mitigate these risks, clinics should prioritize sourcing Revolax Fine, and other injectables like Elasty Plus 1CC, from reputable wholesale distributors. A transparent supply chain ensures the authenticity and integrity of the product from manufacturer to clinic. Referencing professional sourcing guides, such as Coretox 100 Units Wholesale: A Sourcing Guide for Aesthetic Professionals, can provide additional context on best practices.

When purchasing Revolax Fine or other hyaluronic acid fillers like UNIONFILL, professional buyers should demand specific documentation to verify authenticity and regulatory compliance:

• Certificate of Authenticity (CoA): Issued by the manufacturer, confirming the product's origin and specifications for the specific batch.
• Certificate of Analysis (CoA): For the specific lot number, detailing quality control tests and results.
• Batch/Lot Number Traceability: Full traceability from the manufacturer through the distribution chain.
• Manufacturer's Declaration of Conformity: For CE-marked products, confirming compliance with relevant EU directives.
• Proof of Local Regulatory Approval: Documentation from the destination country's health authority, if applicable.
• Cold Chain Documentation: Evidence that temperature-sensitive products were maintained within required ranges during transit.

Understanding the wholesale pricing structure is crucial for inventory management and clinic profitability. Illustrative pricing for Revolax Fine stands at $65.2/unit, with volume-based tier discounts available for professional buyers:

Note: These prices are illustrative and subject to change based on market conditions, specific distributor agreements, and regional tariffs.